Villous sprouting: Fundamental mechanisms of human placental development

Human Reproduction Update

Volumn 6, Issue 5, 2000, Pages 485-494

  Castellucci, M ^a   Kosanke, G ^b   Verdenelli, F ^a   Huppertz, B ^b   Kaufmann, P ^b  

^a Institute of Normal Human Morphology   (Italy)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Chorionic villi; Extracellular matrix; Growth factors; Placenta

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TENASCIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL PROLIFERATION; CHORION VILLUS; CONTROLLED STUDY; CYTOTROPHOBLAST; EXTRACELLULAR MATRIX; FIRST TRIMESTER PREGNANCY; HUMAN; MATURATION; MESENCHYME; MORPHOGENESIS; PATHOGENESIS; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; STROMA CELL; SYNCYTIUM; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; VASCULARIZATION;

EID: 0033815523     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.5.485     Document Type: Review

References (77)

1. The fetal origins of diseases of old age
2. Intrauterine programming of adult disease
3. Fetal nutrition and cardiovascular disease in adult life
4. Allgemeine und spezielle Pathologie der Plazenta
5. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
6. A three-dimensional study of the normal human placental villous core. II. Stromal architecture
7. The development of the human placental villous tree
8. The human placenta: A model for tenascin expression
9. Tenascin interferes with fibronectin action
10. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
11. Expression of bFGF, PIGF and their receptors in the human placenta
12. Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A
13. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
14. Integral membrane heparan sulfate proteoglycans
15. Fetal vasculogenesis and angiogenesis in human placental villi
16. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin
17. Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern
18. Formation and differentiation of extraembryonic mesoderm in the rhesus monkey
19. Molecular and biological properties of the vascular endothelial growth factor family of proteins
20. Distribution of hyaluronate receptors in the adult lung
21. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms
22. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression
23. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes
24. Increased fetoplacental angiogenesis during first trimester in anaemic women
25. Classification of human placental villi. I. Histology
26. Development and anatomy of the placenta
27. Development of the vascular system in the placenta
28. Localisation of placenta growth factor (PlGF) in human term placenta
29. Ultrastructural differentiation of stromal and vascular components in early macaque placental villi
30. Placental pathology in obstetrics: Adaptation or failure of the villous tree?
31. Oxygen and placental villous development: Origins of fetal hypoxia
32. Branching patterns of human placental villous trees: Perspectives of topological analysis
33. Growth zones of the human placental villous trees
34. Tenascin expression during wound healing in human skin
35. Hyaluronan
36. Isolation of endothelial cells from human term placental villi using immunomagnetic beads
37. Localization of vascular endothelial growth factor and its receptor in pregnancy
38. The c-ets1 protooncogene is expressed in human trophoblast during the first trimester of pregnancy
39. Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms
40. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms
41. In vitro angiogenesis on the human amniotic membrane: Requirement for basic, fibroblast growth factor-induced proteinases
42. Regulation of angiogenesis in vitro
43. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
44. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta
45. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin
46. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes
47. Influences of the intrauterine metabolic environment on adult disease: What may we infer from size at birth?
48. Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel
49. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis
50. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy
51. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms
52. Extracellular proteins that modulate cell-matrix interactions
53. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation
54. The placenta in acute toxemia. A comparative study
55. Alterations of the fetal capillary bed in the guinea pig placenta following long-term hypoxia
56. Histometric investigations in placentones (materno-fetal circulation units) of human placentae
57. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
58. Immunohistochemical localization of vascular endothelial growth factor in the human placenta
59. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast
60. Macrovascular and microvascular endothelium during long-term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties
61. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction
62. Proteoglycans and hyaluronan in morphogenesis and differentiation
63. Hyaluronan and cell locomotion
64. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate
65. CD44: The hyaluronan receptor
66. CD44 positive macrophages take up hyaluronan during lung development
67. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo
68. Expression of the vascular endothelial growth factor receptor, KDR, in human placenta
69. C-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans
70. Angiogenic potential of the avian somite
71. Development of the embryonic vascular system
72. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor